Align Technology, Inc. (ALGN)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for ALGN is $198.96, 35.1% above the last close of $147.31 on Oct 16, 2026; targets range from $167.50 to $239.34. Rating consensus: Buy.
Snapshot
- P/E25.6x
- P/E vs sector-9.2%
- P/E vs own-6.9%
- Target upside+35.1%
- ConsensusBuy
- Market cap$10.46B
- FCF yield+7.2%
- InsidersNone in 90d
- Earnings in12d
- News
Why it moved
Align Technology, Inc. (ALGN) fell 1.4% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
2 stories on the day (30-day average 0.4).
- Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court
- Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $147.31 · +13.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▼ 100▼ 200▼
- Above MAs1 of 4 above
- MA20×50↑ in ~31d
- RSI50
- Support-1.7%
- Resistance+4.7%
- Off 52w high-25.4%
- Off ATH-79.8%
- 52w range$147.31
- Bollingerupper half
- MACD1.26
- ATR+3.0%
- Volume1.0x
Analyst price targets
12 firms with a target in the last 12 months · last close $147.31 · as of Oct 16, 2026
Strong buy 3 · Buy 7 · Hold 7 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +4.3% year over year, free cash flow 21.2% of revenue, operating margin 11.7%.
| Q2 FY2026 | Jun 30, 2026 | $1.06B | 1.52 | $224M | 65.1% | 11.7% | 10.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.04B | 1.57 | $120M | 70.8% | 16.6% | 10.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.05B | 1.89 | $290M | 65.7% | 15.2% | 13.0% |
| Q3 FY2025 | Sep 30, 2025 | $996M | 0.78 | $122M | 64.2% | 9.7% | 5.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.01B | 1.72 | $154M | 69.9% | 16.1% | 12.3% |
| Q1 FY2025 | Mar 31, 2025 | $979M | 1.27 | $27.39M | 69.5% | 13.4% | 9.5% |
| Q4 FY2024 | Dec 31, 2024 | $995M | 1.39 | $263M | 70.0% | 14.5% | 10.4% |
| Q3 FY2024 | Sep 30, 2024 | $978M | 1.55 | $234M | 69.7% | 16.6% | 11.9% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 2 |  | $44.39 | +0.6% | -57.7% | +50.1% | 18.0 | $64.33B | |
| 3 |  | $86.60 | -1.7% | -9.0% | +15.2% | 49.8 | $49.9B | |
| 4 |  | $86.04 | -1.9% | -6.8% | +12.7% | 34.0 | $32.47B | |
| 5 |  | $69.57 | -1.1% | -21.0% | +20.2% | 20.2 | $31.42B | |
| 6 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 7 | | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B | |
| 8 |  | $141.10 | +1.7% | -59.3% | +32.3% | 26.4 | $9.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.